<DOC>
	<DOCNO>NCT01418209</DOCNO>
	<brief_summary>The primary objective study determine efficacy low-dose oral ( mouth ) 17-ß-estradiol non-hormonal drug venlafaxine XR compare placebo reduce hot flash . Included objective intention compare venlafaxine XR estradiol therapy , provide evidence relative efficacy venlafaxine currently consider establish also controversial therapy . 17-ß-estradiol type estrogen . Venlafaxine XR extend release ( XR ) version venlafaxine . Venlafaxine XR serotonin-norepinephrine reuptake inhibitor ( SNRI ) . A placebo substance contain medication .</brief_summary>
	<brief_title>MsFLASH-03 : Comparative Efficacy Low-Dose Estradiol Venlafaxine XR Treatment Menopausal Symptoms</brief_title>
	<detailed_description>The MsFLASH-03 study ( Menopausal Strategies : Finding Lasting Answers Symptoms Health - 03 ) , Comparative Efficacy Low-Dose Estradiol SNRI Venlafaxine XR Treatment Menopausal Symptoms , randomize , double-blind , placebo-controlled , three arm clinical trial . The design include : 3 week daily record hot flash prior drug treatment ; 8 week double-blind treatment oral estradiol , venlafaxine , placebo ; follow 14 day drug taper venlafaxine 14 day progesterone treatment estradiol ; follow 2 week treatment group ; telephone follow-up post-treatment .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Females age 4062 year Postmenopausal perimenopausal Having bothersome hot flash In general good health Signed informed consent Recent use systemic hormone therapy hormonal contraceptive Recent use prescribe , overthecounter herbal therapy take specifically hot flash Recent use selective estrogen receptor modulators ( SERMS ) aromatase inhibitor Recent use psychotropic medication , include SSRIs ( selective serotonin reuptake inhibitor ) , serotoninnorepinephrine reuptake inhibitor ( SNRIs ) , MAOIs ( monoamine oxidase inhibitor ) , antidepressants anxiolytic . Known hypersensitivity contraindication ( reason take ) venlafaxine , estrogen , progestins Not use medically approve method birth control , sexually active 12 month since last menstrual period Recent drug alcohol abuse Lifetime diagnosis psychosis bipolar disorder Suicide attempt past 3 year current suicidal ideation Current major depression ( assessed screening ) Pregnancy , intend pregnancy , breast feeding History : Prebreast cancer highrisk breast cancer condition Abnormal bleed suggestive endometrial precancer endometrial hyperplasia Asthma , diabetes mellitus , epilepsy , migraine disorder stable medical management Abnormal screen blood test Current participation another drug trial intervention study Inability unwillingness complete study procedure</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>62 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Vasomotor</keyword>
	<keyword>Symptoms</keyword>
	<keyword>Estradiol</keyword>
	<keyword>Venlafaxine</keyword>
</DOC>